From Triple- to Penta-Exposed Multiple Myeloma: A Real-World Study in a Medicare Population.

In this study across a spectrum of Medicare TCE patients, there was heterogeneity in treatment regimens, suggesting no standard of care. TTD and OS were short, and HRU and HCC were high. These results underscore the potential for new therapies in this population.